Aspire Biopharma Holdings, Inc. (ASBP)
0.0587
-0.02
(-26.44%)
USD |
NASDAQ |
Jan 14, 16:00
0.0573
0.00 (0.00%)
After-Hours: 20:00
Aspire Biopharma Holdings EPS Diluted (Quarterly): -0.0374 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Decoy Therapeutics, Inc. | -1.814 |
| Olema Pharmaceuticals, Inc. | -0.4924 |
| Invivyd, Inc. | -0.0615 |
| Aclarion, Inc. | -2.930 |
| Acrivon Therapeutics, Inc. | -0.4729 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.850M |
| Revenue (Quarterly) | 0.0019M |
| Total Expenses (Quarterly) | 1.852M |
| Enterprise Value | 12.99M |
| Gross Profit Margin (Quarterly) | 47.37% |
| Profit Margin (Quarterly) | -97.39K% |
| Earnings Yield | -2.81K% |
| Normalized Earnings Yield | -1471.04 |